top of page

25-03-06
2025 will be a busy year for LSL Pharma Group
LSL Pharma Group will be focusing in particular on the development of new ophthalmic products. In the photo, we see the president and CEO François Roberge and the executive vice-president and CFO Luc Mainville.
Please click on the following link to read the full article (in French)
bottom of page